Emergence of new manifestations during infliximab treatment in Behçet's syndrome.
Nur Beyza TukekSinem Nihal EsatogluGülen HatemiElif Buse CalıskanYılmaz OzyazganDidar UcarYesim OzgulerEmire SeyahiMelike MelikogluUgur UygunogluAksel SivaZekayi Kutlubayİbrahim HatemiAykut Ferhat CelikSerdal UğurluIzzet FreskoSebahattin YurdakulHasan YaziciSinem Nihal EsatogluPublished in: Rheumatology (Oxford, England) (2022)
New manifestations developed during IFX treatment in 7% of our patients with BS. They could be managed by intensifying IFX treatment or adding other agents in the majority of these manifestations.
Keyphrases